| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 41 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Hirano Patricia C | See Remarks | Sell | 3,108 | $49.43 | $153,626.63 | -1.4% | -8.7% | +21.1% | |
| Aug 29, 2024 | Anish Bhatnagar | Chief Executive Officer | Sell | 115,004 | $47.43 | $5,454,707.25 | -3.6% | +19.9% | +45.3% | |
| Aug 29, 2024 | MacKaness James H | Chief Financial Officer | Sell | 13,531 | $47.43 | $641,782.70 | -2.5% | +19.9% | +45.3% | |
| Aug 29, 2024 | Yen Kristen | See Remarks | Sell | 10,705 | $47.43 | $507,744.55 | -2.9% | +19.9% | +45.3% | |
| Aug 29, 2024 | Hirano Patricia C | See Remarks | Sell | 10,705 | $47.43 | $507,744.55 | -2.3% | +19.9% | +45.3% | |
| Aug 29, 2024 | Vivo Opportunity, LLC67 | 10% Owner | Sell | 1,025,000 | $48.01 | $49,210,750.00 | -5.0% | +19.9% | +45.3% | |
| Aug 6, 2024 | Yen Kristen | See Remarks | Sell | 10,974 | $45.60 | $500,398.37 | -2.2% | +20.1% | +73.7% | |
| Aug 6, 2024 | MacKaness James H | Chief Financial Officer | Sell | 14,983 | $45.60 | $683,201.60 | -2.0% | +20.1% | +73.7% | |
| Aug 6, 2024 | Hirano Patricia C | See Remarks | Sell | 11,009 | $45.60 | $501,993.99 | -1.7% | +20.1% | +73.7% | |
| Aug 6, 2024 | Anish Bhatnagar | Chief Executive Officer | Sell | 127,344 | $45.60 | $5,806,696.14 | -2.7% | +20.1% | +73.7% |